V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008575 | 190006048 | 1.77 | 70 | Palliative (P) | 2018-06-21 | 2018-11-15 | Etoposide oral | 02 | Y | CISPLATIN + RT | 101320016 |
| 190008579 | 190006049 | 1.85 | 66.4 | Palliative (P) | 2021-12-30 | 2022-01-03 | ETOPOSIDE | 02 | null | CAPECITABINE + CARBOPLATIN | 101327356 |
| 190008608 | 190006050 | 1.79 | 93.4 | Palliative (P) | 2018-05-31 | 2018-12-05 | MAP + MIFAMURTIDE | null | null | CAPECITABINE + IRINOTECAN | 100150733 |
| 190008609 | 190006051 | 1.81 | 59.8 | null | 2022-04-11 | 2022-04-25 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | DOXORUBICIN | 101054051 |
| 190008610 | 190006052 | 1.53 | 68.5 | null | 2020-07-06 | 2020-07-25 | Doxorubicin + Methotrexate | 02 | null | BEVACIZUMAB | 101047466 |
| 190008614 | 190006053 | 0 | 44.4 | Curative (C) | 2020-03-21 | 2020-03-28 | GEMCITABINE | 02 | N | FLUOROURACIL + IRINOTECAN | 100353650 |
| 190008623 | 190006054 | 1.68 | 64.7 | Curative (C) | 2018-10-14 | 2018-10-14 | CAPECITABINE + OXALIPLATIN | Y | Y | DOXORUBICIN + OLARATUMAB | 100687787 |
| 190008626 | 190006055 | 0 | 26.1 | null | 2018-08-19 | 2018-08-23 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100506170 |
| 190008638 | 190006056 | 1.58 | 44.8 | null | 2019-01-24 | 2019-02-14 | NB HRNBL-1 BUMEL MAT | 02 | N | ATEZOLIZUMAB | 101067062 |
| 190008644 | 190006057 | 1.92 | 31.3 | null | 2019-11-01 | 2019-11-08 | OST Euramos 1 Closed Trial - AP | 02 | N | CISPLATIN + ETOPOSIDE | 101621193 |
| 190008646 | 190006058 | 0 | 36.1 | null | 2021-07-09 | 2022-01-25 | Carboplatin + Paclitaxel (3 weekly) | 2 | null | CARBOPLATIN + PACLITAXEL | 100578009 |
| 190008647 | 190006059 | 0 | 0 | null | 2018-11-27 | 2018-12-16 | CARBOPLATIN + GEMCITABINE | 01 | N | DOCETAXEL | 100996805 |
| 190008653 | 190006060 | 0 | 22 | null | 2020-01-09 | 2020-01-09 | FLUOROURACIL + OXALIPLATIN | 01 | null | CAPECITABINE + OXALIPLATIN | 101682415 |
| 190008664 | 190006061 | 1.54 | 0 | null | 2021-11-27 | 2021-11-29 | VAI (Ifos 3g/m2) | N | N | CAPECITABINE + CISPLATIN | 101867880 |
| 190008669 | 190006062 | 1.78 | 89.4 | Curative (C) | 2021-09-04 | 2021-09-07 | Ifosfamide | 2 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100338900 |
| 190008671 | 190006063 | null | 98.3 | null | 2017-01-28 | 2017-07-07 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | DOCETAXEL | 101855085 |
| 190008677 | 190006064 | 1.5 | 11 | null | 2019-10-31 | 2019-11-30 | PAM x 2 post-surgery (cycles 3&4) | N | null | CNS ATRT VCA VINC/DACTINO/CYCLOPHOS | 100630635 |
| 190008679 | 190006065 | 1.63 | 94.9 | Curative (C) | 2018-02-09 | 2018-02-10 | EW Rel Irinotecan & Temozolomide | 02 | N | AVELUMAB | 100721567 |
| 190008687 | 190006066 | 1.6 | 64.6 | Curative (C) | 2018-04-16 | 2018-05-07 | EW EuroEwing 2012 Arm A VAI | 02 | N | CAPECITABINE + OXALIPLATIN | 101280432 |
| 190008693 | 190006067 | 1.63 | 71.7 | Palliative (P) | 2020-01-09 | 2020-01-10 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100593995 |
| 190008697 | 190006068 | 1.72 | 79.1 | Palliative (P) | null | 2018-09-21 | Capecitabine + Oxaliplatin 21day | 01 | N | ATEZOLIZUMAB | 101483685 |
| 190008716 | 190006069 | 1.63 | 99.2 | null | 2021-06-18 | 2021-07-14 | OST Euramos 1 Closed Trial - IE | 2 | Y | TRANSPLANT CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 100394790 |
| 190008738 | 190006070 | 1.85 | 76 | Curative (C) | null | 2018-08-05 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101142328 |
| 190008752 | 190006071 | 1.88 | null | null | 2019-08-27 | 2020-04-21 | DHAP | N | N | EPIRUBICIN | 100001977 |
| 190008759 | 190006072 | 1.79 | 109 | Adjuvant (A) | 2020-04-19 | 2020-04-30 | Cisplatin + Radiotherapy | 02 | null | EVEROLIMUS | 100237059 |
| 190008763 | 190006073 | null | null | Palliative (P) | 2020-10-14 | 2021-04-03 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | CETUXIMAB + RT | 101179629 |
| 190008779 | 190006074 | 0 | 38.4 | Neo-adjuvant (N) | 2017-05-20 | 2017-06-03 | BLEOMYCIN | 02 | null | BEVACIZUMAB | 100199904 |
| 190008781 | 190006075 | 1.45 | 24.9 | Palliative (P) | 2021-05-21 | 2021-05-26 | Cisplatin | 02 | N | CAPECITABINE | 100245881 |
| 190008786 | 190006076 | 1.78 | 60.8 | Curative (C) | 2020-04-12 | 2020-04-12 | Liposomal Doxorubicin 50mg/m2 | null | null | PACLITAXEL | 100012646 |
| 190008787 | 190006077 | 1.87 | null | null | 2017-03-12 | 2017-03-23 | EW EuroEwing 2012 Arm B VDC | 02 | null | CAPECITABINE + MITOMYCIN | 101771553 |
| 190008789 | 190006078 | 1.57 | 87 | Palliative (P) | 2016-05-10 | 2016-05-23 | ETOPOSIDE | 01 | N | NIVOLUMAB | 101074975 |
| 190008797 | 190006079 | 1.7 | 93.4 | Palliative (P) | 2018-08-01 | 2018-12-07 | Cisplatin + Fluorouracil + RT 5day | 02 | N | STS NON-RHABDO EPSSG 2005 IE | 100159544 |
| 190008800 | 190006080 | 0 | 27.8 | Palliative (P) | 2017-10-05 | 2018-03-03 | EURAMOS TRIAL | 02 | null | IRINOTECAN | 101646189 |
| 190008801 | 190006081 | 0 | 83.5 | null | 2016-08-16 | 2016-08-16 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | CAPECITABINE | 100464005 |
| 190008805 | 190006082 | 1.8 | 65 | Neo-adjuvant (N) | 2018-07-26 | 2018-07-26 | null | N | N | CARBOPLATIN + FLUOROURACIL | 100930114 |
| 190008807 | 190006083 | 0 | 43.8 | null | 2019-11-17 | 2019-11-17 | NIVOLUMAB | 02 | N | ECX | 100749107 |
| 190008813 | 190006084 | 1.79 | 76.3 | Curative (C) | 2018-03-21 | 2018-04-22 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | TRIAL UNSPECIFIED | 101637746 |
| 190008816 | 190006085 | 1.78 | 20 | Palliative (P) | 2019-12-19 | 2020-01-03 | Carboplatin 21day + Paclitaxel 7day | null | null | CARBOPLATIN + PACLITAXEL | 101513382 |
| 190008817 | 190006086 | 1.8 | 81.5 | null | 2019-11-02 | 2019-11-02 | Cisplatin | 02 | null | CISPLATIN | 101375934 |
| 190008819 | 190006087 | 1.9 | 62.1 | Palliative (P) | 2019-11-02 | 2020-09-28 | OST Mifamurtide | 02 | null | CISPLATIN + PACLITAXEL | 100543326 |
| 190008821 | 190006088 | 1.81 | 109.4 | null | 2018-10-10 | 2018-10-11 | STS Rhabdo RMS 2005 2nd Topo Cyclo | 02 | null | CISPLATIN + GEMCITABINE | 100808096 |
| 190008834 | 190006089 | 0 | 62.3 | Neo-adjuvant (N) | 2019-11-03 | 2020-02-18 | CNS ATRT Carboplatin/Thiotepa + GCSF | 01 | N | TRIAL | 101678873 |
| 190008845 | 190006090 | 1.44 | 91.8 | Adjuvant (A) | 2017-05-15 | 2017-06-09 | Irinotecan + Temozolomide | 02 | Y | NOT MATCHED | 100927741 |
| 190008855 | 190006091 | 0 | 31.2 | Curative (C) | 2018-09-10 | 2020-01-04 | Trial Unspecified | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101595057 |
| 190008856 | 190006092 | 1.17 | 42 | null | 2019-01-09 | 2019-01-21 | DHAP | 01 | N | CISPLATIN + DOCETAXEL | 100851357 |
| 190008859 | 190006093 | 1.78 | 56.9 | null | 2020-08-25 | 2020-08-29 | DHAP | 01 | null | CAPECITABINE | 101563739 |
| 190008862 | 190006094 | 1.67 | 79.6 | Curative (C) | 2016-11-14 | 2016-11-14 | Cisplatin | null | null | CISPLATIN | 101179378 |
| 190008866 | 190006095 | 1.66 | 44 | Curative (C) | 2019-04-08 | 2019-04-23 | ETOPOSIDE | 02 | N | OLAPARIB | 101097471 |
| 190008870 | 190006096 | 1.86 | 54.5 | Neo-adjuvant (N) | 2019-07-01 | 2019-07-01 | EW EuroEwing 2012 Arm A VAI | 02 | N | FLUOROURACIL + IRINOTECAN | 100892480 |
| 190008891 | 190006097 | 1.81 | 51.3 | Curative (C) | 2017-09-26 | 2017-09-28 | EW EuroEwing 99 : VActI | null | null | OLARATUMAB | 101394510 |